PARP Inhibitor IX, EB-47 structure
|
Common Name | PARP Inhibitor IX, EB-47 | ||
---|---|---|---|---|
CAS Number | 366454-36-6 | Molecular Weight | 537.52800 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C24H27N9O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PARP Inhibitor IX, EB-47EB-47, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD+ and extends from the nicotinamide to the adenosine subsite[1]. |
Name | 2-[4-[(2R,3R,4S,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolane-2-carbonyl]piperazin-1-yl]-N-(1-oxo-2,3-dihydroisoindol-4-yl)acetamide |
---|---|
Synonym | More Synonyms |
Description | EB-47, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD+ and extends from the nicotinamide to the adenosine subsite[1]. |
---|---|
Related Catalog | |
Target |
ARTD1/PARP1:45 nM (IC50) |
In Vitro | EB-47 shows inhibition in excess of 50% with CdPARP, and it is able to inhibit CdPARP and HsPARP with IC50 values of 0.86 and 1.0 µM, respectively[1]. |
In Vivo | EB-47 (2 μM; 5 days) decreases the number of embryo implantation sites and blastocysts at day 5. PARP1 participates in the process of embryo implantation[3]. |
References |
Molecular Formula | C24H27N9O6 |
---|---|
Molecular Weight | 537.52800 |
Exact Mass | 537.20800 |
PSA | 208.04000 |
4-[1-(6-Amino-9H-purin-9-yl)-1-deoxy-|A-D-ribofuranuronoyl]-N-(2,3-dihydro-1-oxo-1H-isoindol-4-yl)-1-piperazineacetamide Dihydrochloride |
5'-Deoxy-5'-[4-[2-[(2,3-dihydro-1-oxo-1H-isoindol-4-yl)amino]-2-oxoethyl]-1-piperazinyl]-5'-oxoadenosine Dihydrochloride |
EB 47 |